Detalles de la búsqueda
1.
Prognostic value of prognostic nutritional index and its variations in advanced non-small-cell lung cancer patients treated with anlotinib monotherapy.
J Clin Lab Anal
; 36(4): e24300, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179795
2.
Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
J Clin Lab Anal
; 36(12): e24772, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36441595
3.
Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
Lipids Health Dis
; 20(1): 165, 2021 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34801029
4.
[Effects of Renshenjian Decoction on blood and urine metabonomics in type 2 diabetes rats based on ~1H-NMR].
Zhongguo Zhong Yao Za Zhi
; 45(9): 2186-2192, 2020 May.
Artículo
en Zh
| MEDLINE | ID: mdl-32495570
5.
Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients.
Front Oncol
; 13: 1216852, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37456254
6.
Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib.
Dis Markers
; 2022: 5879137, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356064
7.
Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus.
Cancer Manag Res
; 13: 1075-1085, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574705
Resultados
1 -
7
de 7
1
Próxima >
>>